Antiplatelet therapy in patients with Covid-19: A retrospective observational study

Jozef Banik1, Vojtech Mezera2, Christian Köhler1

  • 1Klinikum Fichtelgebirge Haus Selb Medizinische Klinik, Weißenbacher Str. 62, 95100, Selb, Germany.

Thrombosis Update
|April 15, 2024
PubMed

Insights

Antiplatelet therapy in COVID-19 patients showed more typical radiological findings but did not impact ventilation needs or outcomes. Mechanical ventilation remained the strongest predictor of a poor outcome in these patients.

Area of Science:

  • Cardiology
  • Pulmonology
  • Infectious Diseases

Background:

  • COVID-19 presents a significant risk for both venous and arterial thromboembolism.
  • The role of antiplatelet therapy in modifying the disease course of COVID-19 requires further investigation.

Purpose of the Study:

  • To investigate the effect of antiplatelet therapy on the clinical course and outcomes of hospitalized COVID-19 patients.
  • To identify predictors of adverse outcomes, including the need for mechanical ventilation and typical radiological findings.

Main Methods:

  • A cohort of 152 hospitalized COVID-19 patients was evaluated.
  • Data collected included demographics, comorbidities, medication use (antiplatelets, anticoagulants), laboratory findings, and mechanical ventilation status.
  • Patient outcomes were categorized as 'good' (discharged) or 'bad' (deceased or referred to higher care).

Main Results:

  • The need for mechanical ventilation was the strongest predictor of a bad outcome.
  • Patients on antiplatelet medication showed a higher incidence of typical radiological findings.
  • Factors predicting the need for ventilatory support included elevated LDH and CRP levels, cardiac conduction abnormalities, and chronic lung conditions.

Conclusions:

  • While antiplatelet use correlated with typical radiological findings in COVID-19, it did not alter ventilation requirements or patient outcomes.
  • Mechanical ventilation remains the most critical factor associated with poor prognosis in COVID-19 patients.
Abstract